G

Ghent University Hospital | General and Hepatobiliary Surgery

Research site
(Unclaimed)
Location
Corneel Heymanslaan 10, Gent, East Flanders, Belgium

Site insights

Top conditions

Top treatments

Dexamethasone
Bortezomib
Lenalidomide
Pomalidomide
Psilocybin
Elotuzumab
PLN-74809

Parent organization

This site is a part of Ghent University Hospital

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 5 total trials

A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide (MonumenTAL-6)

The purpose of this study is to compare the effectiveness of either talquetamab plus pomalidomide (Tal-P) or talquetamab plus teclistamab (Tal-Tec) w...

Enrolling
Relapsed or Refractory Multiple Myeloma
Drug: Elotuzumab
Drug: Dexamethasone

A clinical trial of AAV5-hRKp.RPGR vector for participants with X-linked retinitis pigmentosa (XLRP)

Active, not recruiting
X-Linked Retinitis Pigmentosa
Biological: Genetic: AAV5-hRKp.RPGR Intermediate Dose
Biological: Genetic: AAV5-hRKp.RPGR Low Dose

Trial sponsors

G
J
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems